Mike Birbiglia admires his mom’s ‘Forrest Gump’ energy
A note from Wild Card host Rachel Martin: It’s not very often that I listen to a middle aged man from Massachusetts who tells jokes for a living and think to myself, “That dude gets me.” But I actually think Mike Birbiglia and I might have been separated at birth. I know there are big differences. I’m from Idaho, he’s from New England. He is hilarious. I can’t even get my kids to laugh at my jokes. But there are a lot of parallels.
Mike was raised in a really religious family – so was I. His Dad preferred reading books about world wars instead of parenting. Same. He’s an extrovert married to an introvert and we are both perplexed when our kids ask us to explain the world. And he also hosts a podcast where he likes to ask really deep questions, point blank, to many of his guests. I mean, come on. This was meant to be.
Birbiglia’s new comedy special is called The Good Life.
PBS cuts 15% of jobs in wake of federal funding cut
After Congress clawed back public media funding PBS cuts 15% of its staff. More than 100 jobs jobs are being lost.
President Trump plans to rename the Defense Department as the Department of War
The change would return the department to a name that it carried for much of its history, until it became the Department of Defense in the wake of World War II.
The U.S. is designating Ecuador’s largest gangs as terrorists
The U.S. is designating Ecuador's two largest gangs — Los Choneros and Los Lobos — as foreign terrorist organizations.
For mixed status families, deportation fears cast shadow over new academic year
As the new school year begins, mixed immigration status families face heightened fears about ICE enforcement near schools, creating anxiety that extends far beyond the classroom.
Senators from both parties grilled RFK Jr. on vaccines and more
In a blistering hearing, Senators from both parties challenged the health secretary to defend his actions, including on vaccines access and CDC leadership.
Why the medical community is thrilled by U.S. support for a ‘breakthrough’ HIV drug
Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of effort will be a model for how it does global health work in the future.
